Dosage and administration
5 drops orally 2 times per day, 1 to 5 days per week, depending on symptoms and provider recommendations. Consult a physician for use in children under 12 years of age.
BioTox DIP
- Manufacturer
- The Wellness Center For Research and Education | Apotheca Company
- Effective date
- 2025-05-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 20:37:26
Label at a glance#
ProductBioTox DIP
Active ingredientACONITUM NAPELLUS, ARSENIC TRIOXIDE, POTASSIUM DICHROMATE, POTASSIUM CHLORIDE, DIBASIC POTASSIUM PHOSPHATE, LACHESIS MUTA VENOM, LYCOPODIUM CLAVATUM SPORE, MERCURIC CYANIDE, PHYTOLACCA AMERICANA ROOT, TOXICODENDRON PUBESCENS LEAF
Label structure9 sections
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS:
Aconitum Napellus 6C, 12C, 30C, 1LM, Arsenicum Album 6C, 12C, 30C, 1LM, Kali Bichromicum 6C, 12C, 30C, 1LM, Kali Muriaticum 6C, 12C, 30C, 1LM, Kali Phosphoricum 6C, 12C, 30C, 1LM, Lachesis Mutus 6C, 12C, 30C, 1LM, Lycopodium Clavatum 6C, 12C, 30C, 1LM, Mercurius Cyanatus 6C, 12C, 30C, 1LM, Phytolacca Decandra 6C, 12C, 30C, 1LM, Rhus Tox 6C, 12C, 30C, 1LM.
INDICATIONS:
Whole body chills, fatigue, fever, or malaise. Noisy breathing or shortness of breath. Rashes or ulcers. Hoarseness or impaired voice. Difficulty swallowing. Coughing, muscle weakness, runny nose, swelling, or swollen lymph nodes.
WARNINGS:
If you are pregnant or breastfeeding, ask a health professional before using this product.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
KEEP OUT OF REACH OF CHILDREN:
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DIRECTIONS:
5 drops orally 2 times per day, 1 to 5 days per week, depending on symptoms and provider recommendations. Consult a physician for use in children under 12 years of age.
INDICATIONS:
Whole body chills, fatigue, fever, or malaise. Noisy breathing or shortness of breath. Rashes or ulcers. Hoarseness or impaired voice. Difficulty swallowing. Coughing, muscle weakness, runny nose, swelling, or swollen lymph nodes.
INACTIVE INGREDIENTS:
Demineralized Water, 25% Ethanol
QUESTIONS:
MFD FOR: The Wellness Center for
Research and Education, Inc.,
1237 S. Victoria, Suite 169
Oxnard, CA 93035 1-866-962-6484
PACKAGE LABEL DISPLAY:
Dr. Theresa Dale's
NDC 50181-0059-1
Homeopathic
BioTox
DIP
1 fl oz (30 ml)
Products#
Every source-derived product name is available through these pages.
- BioTox DIP
- Aconitum Napellus, Arsenicum Album, Kali Bichromicum, Kali Muriaticum, Kali Phosphoricum, Lachesis Mutus, Lycopodium Clavatum, Mercurius Cyanatus, Phytolacca Decandra, Rhus Tox
- ACONITUM NAPELLUS
- ARSENIC TRIOXIDE
- ARSENIC CATION (3+)
- POTASSIUM DICHROMATE
- DICHROMATE ION
- POTASSIUM CHLORIDE
- POTASSIUM CATION
- DIBASIC POTASSIUM PHOSPHATE
- PHOSPHATE ION
- LACHESIS MUTA VENOM
- LYCOPODIUM CLAVATUM SPORE
- MERCURIC CYANIDE
- PHYTOLACCA AMERICANA ROOT
- TOXICODENDRON PUBESCENS LEAF
- WATER
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50181-0059 | 50181-0059-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACONITUM NAPELLUS | U0NQ8555JD | ACTIB |
| ARSENIC TRIOXIDE | S7V92P67HO | ACTIB |
| POTASSIUM DICHROMATE | T4423S18FM | ACTIB |
| POTASSIUM CHLORIDE | 660YQ98I10 | ACTIM |
| DIBASIC POTASSIUM PHOSPHATE | CI71S98N1Z | ACTIB |
| LACHESIS MUTA VENOM | VSW71SS07I | ACTIB |
| LYCOPODIUM CLAVATUM SPORE | C88X29Y479 | ACTIB |
| MERCURIC CYANIDE | RWG7BD1032 | ACTIB |
| PHYTOLACCA AMERICANA ROOT | 11E6VI8VEG | ACTIB |
| TOXICODENDRON PUBESCENS LEAF | 6IO182RP7A | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ab06ce79-856a-4da9-9874-de61e734ec0a | d5db8bd2-9ea2-49bf-9b6e-d26d9f841d81 | 2025-05-30 | Warnings | ab06ce79-856a-4da9-9874-de61e734ec0a d5db8bd2-9ea2-49bf-9b6e-d26d9f841d81 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.